288 related articles for article (PubMed ID: 23881541)
61. Synthesis of hetero-polymer functionalized nanocarriers by combining surface-initiated ATRP and RAFT polymerization.
Huang X; Hauptmann N; Appelhans D; Formanek P; Frank S; Kaskel S; Temme A; Voit B
Small; 2012 Dec; 8(23):3579-83. PubMed ID: 22911545
[TBL] [Abstract][Full Text] [Related]
62. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
[TBL] [Abstract][Full Text] [Related]
63. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
Cho Y; Shi R; Borgens RB; Ivanisevic A
Nanomedicine (Lond); 2008 Aug; 3(4):507-19. PubMed ID: 18694313
[TBL] [Abstract][Full Text] [Related]
64. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
[TBL] [Abstract][Full Text] [Related]
65. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
[TBL] [Abstract][Full Text] [Related]
66. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery.
Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y
Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818
[TBL] [Abstract][Full Text] [Related]
67. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
68. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
[TBL] [Abstract][Full Text] [Related]
69. Bioresponsive mesoporous silica nanoparticles for triggered drug release.
Singh N; Karambelkar A; Gu L; Lin K; Miller JS; Chen CS; Sailor MJ; Bhatia SN
J Am Chem Soc; 2011 Dec; 133(49):19582-5. PubMed ID: 21981330
[TBL] [Abstract][Full Text] [Related]
70. Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.
Li H; Zhang JZ; Tang Q; Du M; Hu J; Yang D
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3426-31. PubMed ID: 23706230
[TBL] [Abstract][Full Text] [Related]
71. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer.
Zhang P; Wu T; Kong JL
ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082
[TBL] [Abstract][Full Text] [Related]
72. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging.
Dai L; Zhang Q; Li J; Shen X; Mu C; Cai K
ACS Appl Mater Interfaces; 2015 Apr; 7(13):7357-72. PubMed ID: 25765172
[TBL] [Abstract][Full Text] [Related]
73. Functionalized mesoporous silica nanoparticles with redox-responsive short-chain gatekeepers for agrochemical delivery.
Yi Z; Hussain HI; Feng C; Sun D; She F; Rookes JE; Cahill DM; Kong L
ACS Appl Mater Interfaces; 2015 May; 7(18):9937-46. PubMed ID: 25902154
[TBL] [Abstract][Full Text] [Related]
74. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
75. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.
Luo Z; Cai K; Hu Y; Zhang B; Xu D
Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747
[TBL] [Abstract][Full Text] [Related]
76. P(EO-co-LLA) functionalized Fe3O4@mSiO2 nanocomposites for thermo/pH responsive drug controlled release and hyperthermia.
Guo W; Yang C; Lin H; Qu F
Dalton Trans; 2014 Dec; 43(48):18056-65. PubMed ID: 25353400
[TBL] [Abstract][Full Text] [Related]
77. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
Zhao Y; Trewyn BG; Slowing II; Lin VS
J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
[TBL] [Abstract][Full Text] [Related]
78. Preparation of biodegradable PEGylated pH/reduction dual-stimuli responsive nanohydrogels for controlled release of an anti-cancer drug.
Zhou T; Zhao X; Liu L; Liu P
Nanoscale; 2015 Jul; 7(28):12051-60. PubMed ID: 26118938
[TBL] [Abstract][Full Text] [Related]
79. Synthesis of cross-linked carboxyl poly(glycerol methacrylate) and its application for the controlled release of doxorubicin.
Gu W; Ma Y; Zhu C; Chen B; Ma J; Gao H
Eur J Pharm Sci; 2012 Oct; 47(3):556-63. PubMed ID: 22884627
[TBL] [Abstract][Full Text] [Related]
80. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
Xiao D; Jia HZ; Ma N; Zhuo RX; Zhang XZ
Nanoscale; 2015 Jun; 7(22):10071-7. PubMed ID: 25978679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
